Association between administration of antacid medication and anastomotic stricture formation following repair of oesophageal atresia
Association between administration of antacid medication and anastomotic stricture formation following repair of oesophageal atresia
Aims of study: Anastomotic stricture is a significant cause of morbidity following repair of oesophageal atresia (OA). Exposure to gastric acid has been postulated to contribute to stricture development and severity leading to prophylactic antacid use by some surgeons. We investigated the association between administration of antacid medication and the development of anastomotic strictures.
Methods: Retrospective case-note review of consecutive infants undergoing repair of OA with distal tracheoesophageal fistula (Type C) between Jan 1994 and Dec 2014. Only infants who underwent primary oesophageal anastomosis at initial surgical procedure were included. Stricture related outcomes were compared initially for infants who received prophylactic antacid medication versus no prophylaxis, and the role of prophylactic antacid medication in stricture prevention was explored in a multivariate model. Outcomes were also compared for infants grouped by antacid use at any stage.
Results: One hundred fourteen infants were included. Sixteen received prophylactic antacid medication at surgeon preference. Of the remaining 98, 44 subsequently received antacid as treatment for gastro-oesophageal reflux (GOR) and 54 never received antacid medication. There was no statistically significant association between incidence of stricture in the first year (10/16 vs 41/98; p=0.18) nor time to first stricture (median 57 days [41-268] vs 102 days [43-320]; p=0.89) and administration of prophylactic antacid medication. Similarly there were no statistically significant associations between incidence of stricture, age at first stricture and number of dilatations, and administration of antacid medication either as prophylaxis nor when given as treatment for symptoms or signs of GOR.
Conclusions: These data do not support the hypothesis that prophylactic antacid medication reduces the incidence or severity of anastomotic stricture following repair of OA. Treatment with antacids may be best reserved for those with symptoms or signs of GOR. Further prospective investigation of the role of antacid prophylaxis on stricture formation following OA repair is warranted.
334-339
Hall, Nigel
6919e8af-3890-42c1-98a7-c110791957cf
Jones, Ceri E.
1c29d621-82b7-4d1d-ab28-03da0cb7fb4d
Smyth, Rachel
2449adb5-3873-4978-9d1a-8b1056498ae2
Drewett, Melanie
017b4e4c-3143-40bf-bd6b-a36a8df51f3e
Burge, David
587fc481-8d2f-4801-94dd-f03ac4410f41
Hall, Nigel
6919e8af-3890-42c1-98a7-c110791957cf
Jones, Ceri E.
1c29d621-82b7-4d1d-ab28-03da0cb7fb4d
Smyth, Rachel
2449adb5-3873-4978-9d1a-8b1056498ae2
Drewett, Melanie
017b4e4c-3143-40bf-bd6b-a36a8df51f3e
Burge, David
587fc481-8d2f-4801-94dd-f03ac4410f41
Hall, Nigel, Jones, Ceri E., Smyth, Rachel, Drewett, Melanie and Burge, David
(2020)
Association between administration of antacid medication and anastomotic stricture formation following repair of oesophageal atresia.
The Journal of Surgical Research, 254, .
(doi:10.1016/j.jss.2020.05.004).
Abstract
Aims of study: Anastomotic stricture is a significant cause of morbidity following repair of oesophageal atresia (OA). Exposure to gastric acid has been postulated to contribute to stricture development and severity leading to prophylactic antacid use by some surgeons. We investigated the association between administration of antacid medication and the development of anastomotic strictures.
Methods: Retrospective case-note review of consecutive infants undergoing repair of OA with distal tracheoesophageal fistula (Type C) between Jan 1994 and Dec 2014. Only infants who underwent primary oesophageal anastomosis at initial surgical procedure were included. Stricture related outcomes were compared initially for infants who received prophylactic antacid medication versus no prophylaxis, and the role of prophylactic antacid medication in stricture prevention was explored in a multivariate model. Outcomes were also compared for infants grouped by antacid use at any stage.
Results: One hundred fourteen infants were included. Sixteen received prophylactic antacid medication at surgeon preference. Of the remaining 98, 44 subsequently received antacid as treatment for gastro-oesophageal reflux (GOR) and 54 never received antacid medication. There was no statistically significant association between incidence of stricture in the first year (10/16 vs 41/98; p=0.18) nor time to first stricture (median 57 days [41-268] vs 102 days [43-320]; p=0.89) and administration of prophylactic antacid medication. Similarly there were no statistically significant associations between incidence of stricture, age at first stricture and number of dilatations, and administration of antacid medication either as prophylaxis nor when given as treatment for symptoms or signs of GOR.
Conclusions: These data do not support the hypothesis that prophylactic antacid medication reduces the incidence or severity of anastomotic stricture following repair of OA. Treatment with antacids may be best reserved for those with symptoms or signs of GOR. Further prospective investigation of the role of antacid prophylaxis on stricture formation following OA repair is warranted.
Text
ASSOCIATION BETWEEN ADMINISTRATION May 2020
- Accepted Manuscript
More information
Accepted/In Press date: 7 May 2020
e-pub ahead of print date: 7 June 2020
Identifiers
Local EPrints ID: 440975
URI: http://eprints.soton.ac.uk/id/eprint/440975
ISSN: 0022-4804
PURE UUID: 40273372-d507-404d-984c-feb44dafe1c4
Catalogue record
Date deposited: 26 May 2020 16:32
Last modified: 17 Mar 2024 05:33
Export record
Altmetrics
Contributors
Author:
Ceri E. Jones
Author:
Rachel Smyth
Author:
Melanie Drewett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics